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Abstract
In the 1950s, based on the theory of stimulating radi-
ant energy published by Albert Einstein in 1916, the col-
laboration of physicists and electrical engineers, search-
ing for monochromatic radiation to study the spectra of 
molecules, led to the invention of the first laser in 1960. 
 Ophthalmologists and dermatologists were the first to 
study the biological effects and therapeutic possibilities 
of laser beams. The construction of new laser systems 
emitting energy at different wavelengths or with different 
durations, as well as the development of new concepts of 
the biomedical effects, led to its broad use in surgery in 
the treatment of vascular and pigmented lesions as well 
as cosmetic applications.
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It was not predictable that an analytical tool for 
physicists to examine the molecular structure of 
molecules would become one of the most im-
portant inventions of the 20th century. Theodore 
Maiman was enthusiastic about the first laser he 
constructed, but regarded it as ‘a solution look-
ing for a problem’ [1]. The expectations during 
the Cold War that lasers could be used as pow-
erful weapons remained unfulfilled. Nonetheless, 
today laser systems are present in almost every 
household, at least in CD players. The accep-
tance of lasers in medicine by doctors as well as 
by patients has always been very high. With a 
positive attitude towards such a powerful source 
of harmless- looking light, lasers became regarded 
as magic bullets for the treatment of cancer, re-
placing the bloody knife of the surgeons.
The history of laser is very young and tells of 
an invention of great economic value. However, 
this makes it very difficult to interpret the differ-
ent references, which are predominantly scientific 
papers and autobiographical retrospections of the 
people involved. Depending on the intention and 
the background of the authors, selection and em-
phasis vary.
Inventing the Laser
In 1916, Albert Einstein discussed the possibil-
ity of stimulating radiant energy based on Niels 
Bohr’s theory that atoms emitted energy in quan-
ta when transitioning from excited states back to 
resting states [2]. The first experimental proof of 
his theory was published by the German physicists 
Rudolf Ladenburg and Hans Kopfermann in 1928 
[3]. However, stimulated emission received little 
attention from experimentalists during the 1920s 
and 1930s when atomic and molecular spectros-
copy were of central interest to many physicists 
[4]. In 1939, Valentin A. Fabrikant defended his 
doctoral thesis, ‘The emission mechanism of a gas 
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discharge’, at the P.N. Lebedev Physical Institute in 
Moscow. It discussed experimental evidence for 
the existence of negative absorption (what was lat-
er called stimulated emission) and suggested ex-
periments on light amplification [5].
Although the essential ideas for constructing 
a laser were known around 1930, it was not be-
fore the early 1950s that physicists and electrical 
engineers began to collaborate with the research 
on monochromatic radiation of constant am-
plitude at very small wavelengths studying the 
microwave and radio frequency spectra of mol-
ecules. In this context, in 1953 and 1954, sever-
al physicists independently suggested the use of 
stimulated emission for microwave amplifica-
tion, creating the acronym MASER to stand for 
‘microwave amplification by stimulated emis-
sion of radiation’ [6].
In 1953, the American physicist Joseph Weber 
at the University of Maryland published a pro-
posal for a microwave amplifier that was based 
on stimulated emission in a paramagnetic solid 
[7]. In 1954, Nikola G. Basov and Alexander M. 
Prokhorov of the Lebedev Institute in Moscow and 
J.P. Gordon, H.J. Zeiger, and Charles H. Townes 
of Columbia University in New York reported on 
two molecular devices for generating microwave 
radiation, both using the ammonia molecule as 
the active species [8, 9].
Charles H. Townes, Nikolay G. Basov, and 
Alexander M. Prokhorov received the Nobel Prize 
in Physics 1964 for their ‘fundamental work in the 
field of quantum electronics which has led to the 
construction of oscillators and amplifiers based 
on the maser- laser principle’ [10].
The ammonia beam maser itself was not par-
ticularly useful as its operation was limited to 
the resonant frequency of the ammonia mole-
cule and could only be used at barely detectable 
power levels [1]. In 1958, C.H. Townes and his 
brother- in- law Arthur Leonard Schawlow, pro-
fessor at Stanford University, showed that ma-
sers could theoretically be made to operate in 
the  optical and infrared regions [11]. The same 
year, G. Makov, C. Kikuchi, J. Lambe and R.W. 
Terhune at the University of Michigan developed 
and built a solid- state maser [12]. They used 
crystalline corundum (ruby) in a large magnetic 
field and a strategy similar to that known as opti-
cal pumping, suggested by Nicolas Bloembergen 
at Harvard University in 1956 [13]. Theodore H. 
Maiman at the Hughes Corporation Research 
Laboratories took over the Kikuchi ruby maser. 
In 1960, he presented the first functional optical 
ruby maser excited by a xenon flash lamp to pro-
duce a bright pulse of 693.7 nm, deep red light 
of about a 1- ms duration and a power output of 
about a billion watt per pulse [14]. His invention 
rapidly led to the development of multiple other 
optical masers, now called laser (light amplifi-
cation by stimulated emission of radiation). In 
1961, Fred J. McClung and Robert W. Hellwarth 
introduced the quality- switching (Q- switching) 
technique to shorten the pulse length to nano-
seconds with the use of an electro- optical shut-
ter that permitted the storage and subsequent re-
lease of a peak power up to gigawatts of energy 
[15, 16].
Medical Use of Lasers
The medical specialists who were already treating 
diseases with sunlight and technical light sourc-
es were also the first to carry out biomedical re-
search with lasers.
One year after Maiman had presented the first 
ruby laser, ophthalmologists using xenon lamps 
for retinal photocoagulation published on ocular 
lesions experimentally produced in a rabbit by an 
optical maser [17]. These studies were soon fol-
lowed by clinical experience on patients treated 
for retinal tears, flat detachments, angiomas, and 
tumors [18].
In dermatology, the treatment of skin diseases 
with light has a long tradition – e.g. lupus vulgar-
is with the Finsen lamp in 1899, wound healing 
and rickets with artificial UV light sources after 
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1901, and psoriasis with the combination of light 
and tar in 1925. Hence, it is no surprise that the 
American Society for Laser Medicine and Surgery 
honors a dermatologist, Leon Goldman, as the 
‘father of lasers in medicine in the United States’ 
[19]. Leon Goldman did his dermatological train-
ing in Zürich, London, and Cincinnati. He was 
Chairman of the Department of Dermatology at 
the University of Cincinnati when he learned of 
the invention of Theodore Maiman’s ruby laser in 
1960. He was convinced of the great potential of 
lasers in medicine. In 1961, he founded the first 
biomedical laser laboratory at the University of 
Cincinnati [20]. In 1963, Goldman and his co-
 workers published the first study on the effects of 
lasers on skin describing the selective destruction 
of pigmented structures of the skin including hair 
follicles with the beam of the ruby laser. They not-
ed highly selective injury of pigmented structures 
(black hair) with no evident change in the white 
skin underneath [21, 22].
Goldman published on the possible treatment 
of nevi, melanomas, and tattoos using the pulsed 
ruby laser: ‘The most striking results have been 
obtained with the removal of tattoos, especially 
with the Q switched laser’. He expected the laser to 
bring substantial benefits to the treatment of skin 
cancer: ‘Because of the accessibility and color, la-
ser surgery can be used extensively in the field of 
skin cancer. The most significant treatments have 
been given for that black cancer of man, mela-
noma. Here, our laboratory has done laser op-
erations even in delicate areas such as melanoma 
near the brain. It is too early to tell how perma-
nent the effects will be. . .’ [23] (fig. 1).
He preformed clinical and histopatholo gical 
studies on vascular malformations with the ar-
gon laser. In 1973, Goldman published  promising 
effects on angiomas with the  continu ous- wave 
neo dymium:ytt r ium-  a luminium-  gar net 
(Nd:YAG) laser. His book Biomedical Aspects of the 
Laser published in 1967 is a comprehensive over-
view over the possibilities, problems, and ideas of 
the use of the laser in medicine at that time, also 
emphasizing the need for protection from laser 
energy. In addition, he discussed ideas of using 
Fig. 1. Experimental treatment of 
metastatic cutaneous melanoma 
with a pulsed neodymium laser by 
Leon Goldman [23].
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the laser as a diagnostic tool (transillumination) 
to detect foreign bodies, hard tumors, or bone 
defects, and presented data on the use of laser in 
dentistry.
Photoexcision (the optical scalpel) was pos-
sible with continuous- wave lasers all invented in 
1964; first the CO2 laser, followed by the Nd:YAG-
 laser and then the argon laser. For the CO2 laser, 
the color of the target area was not of any great sig-
nificance and with an out- of- focus beam and larg-
er spot size, hemostasis was also possible making 
it a helpful tool for surgery on vasculated organs 
(liver, oral mucosa, gynecology). Developments 
in fiber optics made it possible to transmit far-
 infrared laser beams, increasing the flexibility of 
CO2 lasers for endoscopic surgery. The argon la-
ser showed superior absorption by hemoglobin 
and was used for treating port wine stains and 
teleangiectasia of the face and early rhinophyma 
[24].
The early continuous- wave lasers emitted an 
uninterrupted beam of light that was effective in 
destroying the desired target, but also exposed 
the surrounding healthy tissue to laser energy 
for prolonged periods. The result of this collat-
eral damage was unacceptably high rates of hy-
pertrophic scarring and pigment alteration. The 
first attempt to minimize this nonspecific tissue 
injury involved making the continuous- wave la-
sers discontinuous or quasi- continuous by us-
ing a mechanical shutter to interrupt the beam 
of light. In the treatment of vascular lesions, the 
development of the tunable yellow light dye laser 
with the absorption peak closer to oxyhemoglo-
bin than the early argon lasers reduced the risk 
of side effects. In 1996, the erbium (Er):YAG la-
ser with a very short wavelength of 2,940 nm al-
lowed a more superficial vaporization of tissue 
and was used together with CO2 lasers for skin 
resurfacing. Very recently, the new technical 
concept of fractional photothermolysis was in-
troduced. It received FDA approval in 2004 for 
skin resurfacing and in 2005 for the treatment of 
melasma [25].
Selective Photothermolysis
These developments support the common as-
sumption that progress in medicine (and laser 
dermatology) depends mainly on new technol-
ogy; however, technical progress reflects only one 
part of the history of the laser. Both acceptance of 
and interest in observations depends very much 
on the attitude of the involved persons. Even with-
in the short history of lasers in medicine, the ex-
ample of the pulsed laser systems shows how new 
ideas foster new use of old technology [26].
Leon Goldman wrote in 1967: ‘There is ev-
ery indication that Q- switched lasers will remain 
an important tool in the physicists’ laboratories’ 
[23]. Despite the various treatment possibilities 
that Goldman proposed and the encouraging re-
sults he published, there was an initial lack of in-
terest in the development and support of the use 
of pulsed lasers by the government, industry, and 
the armed forces. Surgeons focused their interest 
on continuous rather than pulsed lasers [24]. The 
ruby laser was ineffective when used as an optical 
scalpel for cutting or coagulation, and when using 
high- energy pulses the effect became unpredict-
able because of cavitations (vapor bubbles). The 
attempts to use the pulsed Nd:YAG laser were not 
more successful as tissue fragments were spattered 
all over the operating room [26]. In the 1980s, the 
pulsed ruby laser was commercialized in Japan for 
the treatment of tattoos and pigmented lesions, 
while being abandoned in Europe and the USA 
where tattoo removal was performed by CO2 laser 
vaporization [27].
With the flashlamp- pumped pulsed dye laser 
in the early 1980s, R. Rox Anderson and John A. 
Parrish from the Department of Dermatology at 
the Harvard Medical School in Boston developed 
the theory of selective photothermolysis that rev-
olutionized the practice of cutaneous laser sur-
gery [28]. The authors recognized that the collat-
eral thermal damage in the surrounding tissue of 
the target chromophore resulted from prolonged 
exposure to the laser’s energy. By the appropriate 
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